<?xml version="1.0" encoding="UTF-8"?>
<ref id="B23">
 <label>23</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Louvet</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Labianca</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Hammel</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Lledo</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Zampino</surname>
    <given-names>MG</given-names>
   </name>
   <name>
    <surname>Andre</surname>
    <given-names>T</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial</article-title>. 
  <source>J Clin Oncol</source> (
  <year>2005</year>) 
  <volume>23</volume>:
  <page-range>3509–16</page-range>.  
  <pub-id pub-id-type="doi">10.1200/JCO.2005.06.023</pub-id>
 </mixed-citation>
</ref>
